- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (19)
- Timeline of Article Publication (0)
- Article Quality Tracking (1)
- Reader Comments (1)
- Reference Citation Analysis (5)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4710)
All Articles published online
|
Publishing Process of This Article
|
Sep 16, 2023 (publication date) through Sep 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation. World J Clin Cases 2023; 11(26): 6066-6072 [PMID: 37731575 DOI: 10.12998/wjcc.v11.i26.6066] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6066.htm |
| Number | Citing Articles |
| 1 |
Christos Kourek, Alexandros Briasoulis, Grigorios Giamouzis, John Skoularigis, Andrew Xanthopoulos. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure. World Journal of Clinical Cases 2023; 11(36): 8603-8605 doi: 10.12998/wjcc.v11.i36.8603
Abstract(711) |
Core Tip(654) |
Full Article(HTML)(1983)
|
Full Article with Cover (PDF)-878K(124)
|
Full Article (Word)-231K(21)
|
Audio-1095K(10)
|
Peer-Review Report-212K(88)
|
Answering Reviewers-119K(92)
|
Full Article (PDF)-514K(165)
|
Full Article (XML)-21K(96)
|
Times Cited (2)
|
Total Visits (5784)
|
Open
|
| 2 |
Yujing Zhang, Pingyan Fei, Xinyu Liu. Serum interleukin-6, tumour necrosis factor-a, D-dimer after recombinant human brain natriuretic peptide combined with levosimendan in patients with heart failure. Journal of Medical Biochemistry 2025; 44(5): 1100 doi: 10.5937/jomb0-56202
|
| 3 |
启俊 刘. Application Progress of Recombinant Human Brain Natriuretic Peptide in Clinical Practice. Advances in Clinical Medicine 2024; 14(04): 2573 doi: 10.12677/acm.2024.1441330
|
| 4 |
Dahuan Shi, Xin Li, Lantao Yang, Chunmei Luo, Jing Ma. Benefits of recombinant human brain natriuretic peptide to improve ventricular function and hemodynamics in patients with ST-elevation myocardial infarction.. Investigación Clínica 2024; 65(3): 335 doi: 10.54817/IC.v65n3a06
|